United Kingdom· GB-APID-8542611000001106
Hyoscine hydrobromide 600micrograms/5ml oral solution
A medicinal product containing hyoscine hydrobromide, registered in United Kingdom by Special Order.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Hyoscine hydrobromide
- Manufacturer
- Special Order
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hyoscine hydrobromide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesscopolamineActavis Pharma, Inc.
- FranceBROMHYDRATE DE SCOPOLAMINE RENAUDIN 0,025 %, solution injectableLABORATOIRE RENAUDIN
- BelgiumBromhydrate de Scopolamine 0,25 mg/mlLaboratoires Sterop
- FinlandOftan-ScopolaminSanten Oy
- CanadaSCOPOLAMINE HYDROBROMIDE INJECTIONOMEGA LABORATORIES LIMITED
- IrelandHyoscine Hydrobromide Martindale Pharma 600 micrograms/ml Solution for InjectionEthypharm
- GermanyBoro-Scopol NOmnivision Gmbh
- NorwayScopodermBaxter Medical AB
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Scopolamine Hbr Sterop
- Germany · Boro-Scopol N, Scopoderm Tts
- Denmark · Scopoderm
- Spain · Escopolamina B. Braun
- Finland · Scopoderm
- France · Bromhydrate De Scopolamine Renaudin, Scopoderm Tts
- Ireland · Hyoscine Injection Bp Ethypharm, Kwells
- Iceland · Scopoderm
- Luxembourg · Scopoderm Tts
- Malta · Kwells
- Netherlands · Scopoderm
- Norway · Scopoderm
- Sweden · Scopoderm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5a78c58-35c3-4ea0-a437-d2b8de157018 GET /v1/drugs/d5a78c58-35c3-4ea0-a437-d2b8de157018?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "8542611000001106",
"desc": "Hyoscine hydrobromide 600micrograms/5ml oral solution (Special Order)",
"form": "Oral solution",
"vpid": "8560911000001109",
"source": "dmd",
"vtm_id": "13868111000001109",
"strength": "120 microgram",
"substance": "Hyoscine hydrobromide",
"ingredient": "Hyoscine hydrobromide",
"supplier_code": "8286711000001104"
}See everything about hyoscine hydrobromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.